397 related articles for article (PubMed ID: 24374889)
1. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.
Aspinall EJ; Nambiar D; Goldberg DJ; Hickman M; Weir A; Van Velzen E; Palmateer N; Doyle JS; Hellard ME; Hutchinson SJ
Int J Epidemiol; 2014 Feb; 43(1):235-48. PubMed ID: 24374889
[TBL] [Abstract][Full Text] [Related]
2. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
4. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.
Fernandes RM; Cary M; Duarte G; Jesus G; Alarcão J; Torre C; Costa S; Costa J; Carneiro AV
BMC Public Health; 2017 Apr; 17(1):309. PubMed ID: 28399843
[TBL] [Abstract][Full Text] [Related]
6. Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).
Palmateer N; Hamill V; Bergenstrom A; Bloomfield H; Gordon L; Stone J; Fraser H; Seyler T; Duan Y; Tran R; Trayner K; Biggam C; Smith S; Vickerman P; Hickman M; Hutchinson S
Int J Drug Policy; 2022 Nov; 109():103872. PubMed ID: 36202039
[TBL] [Abstract][Full Text] [Related]
7. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
8. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
Sawangjit R; Khan TM; Chaiyakunapruk N
Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
[TBL] [Abstract][Full Text] [Related]
10. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis.
Cepeda JA; Burgos JL; Kahn JG; Padilla R; Meza Martinez PE; Segovia LA; Gaines T; Abramovitz D; Rangel G; Magis-Rodriguez C; Vickerman P; Strathdee SA; Martin NK
BMJ Open; 2019 Jan; 9(1):e026298. PubMed ID: 30700490
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.
Abdul-Quader AS; Feelemyer J; Modi S; Stein ES; Briceno A; Semaan S; Horvath T; Kennedy GE; Des Jarlais DC
AIDS Behav; 2013 Nov; 17(9):2878-92. PubMed ID: 23975473
[TBL] [Abstract][Full Text] [Related]
13. Measures of harm reduction service provision for people who inject drugs.
O'Keefe D; Bluthenthal RN; Kral AH; Aitken CK; McCormack A; Dietze PM
Bull World Health Organ; 2019 Sep; 97(9):605-611. PubMed ID: 31474773
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials.
van Santen DK; Lodi S; Dietze P; van den Boom W; Hayashi K; Dong H; Cui Z; Maher L; Hickman M; Boyd A; Prins M
Addiction; 2023 Jun; 118(6):1116-1126. PubMed ID: 36710474
[TBL] [Abstract][Full Text] [Related]
15. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico.
Welch-Lazoritz M; Habecker P; Dombrowski K; Rivera Villegas A; Davila CA; Rolón Colón Y; Miranda De León S
Int J Drug Policy; 2017 May; 43():16-22. PubMed ID: 28160735
[TBL] [Abstract][Full Text] [Related]
16. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.
Des Jarlais DC; Feelemyer JP; Modi SN; Abdul-Quader A; Hagan H
BMC Public Health; 2013 Jan; 13():53. PubMed ID: 23332005
[TBL] [Abstract][Full Text] [Related]
17. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
[TBL] [Abstract][Full Text] [Related]
18. "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Walker S; Curtis M; Kirwan A; Thatcher R; Dietze P
Harm Reduct J; 2024 Feb; 21(1):51. PubMed ID: 38402389
[TBL] [Abstract][Full Text] [Related]
19. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
[TBL] [Abstract][Full Text] [Related]
20. Co-design of harm reduction materials for people who inject drugs to implement research findings.
Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
